These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33646180)

  • 1. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
    Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
    J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic Depletion, β-Amyloid Burden, and Cognition in Lewy Body Disease.
    Yoo HS; Lee S; Chung SJ; Lee YH; Lee PH; Sohn YH; Lee S; Yun M; Ye BS
    Ann Neurol; 2020 May; 87(5):739-750. PubMed ID: 32078179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
    Oh Y; Kim JS; Lyoo CH; Park G; Kim H
    Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
    Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
    Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine transporter uptake, parkinsonism and cognition in Alzheimer's disease.
    Kang S; Jeon S; Lee YG; Ye BS
    Eur J Neurol; 2023 Oct; 30(10):3105-3113. PubMed ID: 37493955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Amyloid Positivity Rate and Accumulation Pattern between Amnestic and Non-Amnestic Type Mild Cognitive Impairment.
    Lee SH; Lee JH; Byun MS; Yi D; Jung G; Park JE; Lee DY
    Psychiatry Investig; 2020 Jun; 17(6):603-607. PubMed ID: 32517418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease.
    Yang Y; Cheon M; Kwak YT
    Dement Neurocogn Disord; 2017 Sep; 16(3):57-63. PubMed ID: 30906372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between striatal amyloid deposition and motor prognosis in Parkinson's disease.
    Park M; Kim HJ; Baik K; Na HK; Lee YG; Yoon SH; Jeong SH; Chung SJ; Shin HW; Lyoo CH; Sohn YH; Lee PH
    Eur J Neurol; 2024 Oct; 31(10):e16364. PubMed ID: 39034046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.
    Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA
    Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing speed is related to striatal dopamine transporter availability in Parkinson's disease.
    Vriend C; van Balkom TD; van Druningen C; Klein M; van der Werf YD; Berendse HW; van den Heuvel OA
    Neuroimage Clin; 2020; 26():102257. PubMed ID: 32344372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.
    Fiorenzato E; Biundo R; Cecchin D; Frigo AC; Kim J; Weis L; Strafella AP; Antonini A
    J Alzheimers Dis; 2018; 66(1):229-237. PubMed ID: 30282359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
    Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
    Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI
    Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.
    Oh YS; Kim JS; Hwang EJ; Lyoo CH
    Parkinsonism Relat Disord; 2018 Nov; 56():47-51. PubMed ID: 29925486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.